<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="735">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04668911</url>
  </required_header>
  <id_info>
    <org_study_id>EDGE 132868</org_study_id>
    <secondary_id>283766</secondary_id>
    <nct_id>NCT04668911</nct_id>
  </id_info>
  <brief_title>Oral Health, Microbial Burden and COVID-19</brief_title>
  <acronym>ORACLE</acronym>
  <official_title>Oral Health, Microbial Burden and COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eastman Dental Insitute and Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DermBiont, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Whittington Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Eastman Dental Insitute and Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study of patients with COVID-19 confirmed cases (with various degrees of&#xD;
      severity) and controls.&#xD;
&#xD;
      Oral and nasal swabs will be taken from 150 patients (50 with mild form and 50 with severe&#xD;
      form of COVID-19 with or without mechanical ventilation, 50 healthy controls).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2020</start_date>
  <completion_date type="Anticipated">December 12, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 12, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oral microbial signature</measure>
    <time_frame>Day 1</time_frame>
    <description>To assess the oral microbial signatures that relates to SARS-CoV2 in patients with no, mild and severe disease.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nasal microbial signature</measure>
    <time_frame>Day 1</time_frame>
    <description>To assess the nasal microbial signatures related to SARS-CoV2 in patients with no, mild and severe disease and to assess the role of the oral expression of ACE2-Ang II system during SARS-CoV2 in relation to disease outcome (mild, severe COVID).</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Covid19</condition>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Controls tested PCR (-) for COVID-19</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Tested PCR (+) for COVID-19, Mild - not admitted to the hospital</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Tested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Swab</intervention_name>
    <description>PCR test for SARS-CoV2, oral and nasal swab</description>
    <arm_group_label>Controls tested PCR (-) for COVID-19</arm_group_label>
    <arm_group_label>Tested PCR (+) for COVID-19, Mild - not admitted to the hospital</arm_group_label>
    <arm_group_label>Tested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Oral and nasal swab&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults who tested (PCR) positive or negative for SARS-CoV2 infection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Must provide written informed consent&#xD;
&#xD;
          2. Subjects have to be tested (PCR) positive or negative for SARS-CoV2 infection&#xD;
&#xD;
          3. Must be able to provide oral and nasal swabbing within 48 hours of polymerise chain&#xD;
             reaction (PCR) test results&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        a. Under the age of 18 years old&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jeanie Suvan</last_name>
    <phone>+442034561108</phone>
    <email>j.suvan@ucl.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>University College Hospital (UCH), UCL Eastman Dental Institute</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco D'Aiuto, DMD, PhD, MClinDent</last_name>
      <email>f.daiuto@ucl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Francesco D'Aiuto, DMD, PhD, MClinDent</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2020</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College, London</investigator_affiliation>
    <investigator_full_name>Prof Francesco D'Aiuto</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Human microbiome</keyword>
  <keyword>Oral microbiome</keyword>
  <keyword>SARS-CoV-2 infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

